Deanna L. Kroetz

11.6k total citations · 1 hit paper
133 papers, 8.6k citations indexed

About

Deanna L. Kroetz is a scholar working on Oncology, Molecular Biology and Biochemistry. According to data from OpenAlex, Deanna L. Kroetz has authored 133 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Oncology, 42 papers in Molecular Biology and 33 papers in Biochemistry. Recurrent topics in Deanna L. Kroetz's work include Drug Transport and Resistance Mechanisms (59 papers), Pharmacogenetics and Drug Metabolism (28 papers) and Eicosanoids and Hypertension Pharmacology (24 papers). Deanna L. Kroetz is often cited by papers focused on Drug Transport and Resistance Mechanisms (59 papers), Pharmacogenetics and Drug Metabolism (28 papers) and Eicosanoids and Hypertension Pharmacology (24 papers). Deanna L. Kroetz collaborates with scholars based in United States, Japan and Denmark. Deanna L. Kroetz's co-authors include Frank J. Gonzalez, Thierry Pineau, Jennie W. Owens, Susanna S.T. Lee, John Drago, Eric J. Lee, Pedro M. Fernández‐Salguero, Heiner Westphal, Leslie W. Chinn and Darryl C. Zeldin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Deanna L. Kroetz

132 papers receiving 8.5k citations

Hit Papers

Targeted Disruption of th... 1995 2026 2005 2015 1995 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deanna L. Kroetz United States 46 3.1k 3.1k 1.9k 1.6k 1.4k 133 8.6k
Edward T. Morgan United States 46 2.3k 0.7× 2.0k 0.7× 3.7k 1.9× 1.3k 0.8× 496 0.4× 120 7.7k
Yoshimichi Sai Japan 49 2.9k 0.9× 4.3k 1.4× 737 0.4× 1.5k 0.9× 2.1k 1.5× 185 8.6k
Kathleen M. Giacomini United States 66 5.3k 1.7× 7.5k 2.4× 2.4k 1.3× 1.7k 1.0× 4.0k 2.8× 289 15.8k
Miki Nakajima Japan 60 4.5k 1.5× 3.0k 1.0× 4.7k 2.5× 600 0.4× 1.1k 0.8× 267 11.0k
Hideyuki Saito Japan 55 2.5k 0.8× 4.9k 1.6× 714 0.4× 1.3k 0.8× 2.6k 1.8× 273 9.5k
Patrick Maurel France 63 3.3k 1.1× 3.9k 1.3× 6.6k 3.4× 857 0.5× 1.2k 0.9× 205 12.8k
Edward L. LeCluyse United States 58 3.0k 1.0× 3.2k 1.1× 4.5k 2.3× 450 0.3× 1.0k 0.7× 135 11.3k
Akira Tsuji Japan 50 2.7k 0.9× 5.3k 1.7× 1.1k 0.6× 1.4k 0.8× 2.5k 1.8× 182 9.5k
Satohiro Masuda Japan 49 1.9k 0.6× 4.6k 1.5× 943 0.5× 777 0.5× 2.9k 2.1× 191 8.8k
Ulf Diczfalusy Sweden 61 5.0k 1.6× 2.8k 0.9× 1.5k 0.8× 943 0.6× 464 0.3× 158 12.7k

Countries citing papers authored by Deanna L. Kroetz

Since Specialization
Citations

This map shows the geographic impact of Deanna L. Kroetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deanna L. Kroetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deanna L. Kroetz more than expected).

Fields of papers citing papers by Deanna L. Kroetz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deanna L. Kroetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deanna L. Kroetz. The network helps show where Deanna L. Kroetz may publish in the future.

Co-authorship network of co-authors of Deanna L. Kroetz

This figure shows the co-authorship network connecting the top 25 collaborators of Deanna L. Kroetz. A scholar is included among the top collaborators of Deanna L. Kroetz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deanna L. Kroetz. Deanna L. Kroetz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hammer, Helen, Flemming Nielsen, Oliver Pötz, et al.. (2024). Modeling mechanisms of chemotherapy-induced peripheral neuropathy and chemotherapy transport using induced pluripotent stem cell-derived sensory neurons. Neuropharmacology. 258. 110062–110062. 2 indexed citations
2.
Yang, Jia, Khondoker Alam, Andre Raw, et al.. (2024). Effect of Antioxidants in Medicinal Products on Intestinal Drug Transporters. Pharmaceutics. 16(5). 647–647. 4 indexed citations
3.
Kroetz, Deanna L., et al.. (2021). Mechanistic insights into the pathogenesis of microtubule‐targeting agent‐induced peripheral neuropathy from pharmacogenetic and functional studies. Basic & Clinical Pharmacology & Toxicology. 130(S1). 60–74. 17 indexed citations
4.
Xiong, Chenling, Tore Bjerregaard Stage, Jeffrey Kim, et al.. (2020). Human Induced Pluripotent Stem Cell Derived Sensory Neurons are Sensitive to the Neurotoxic Effects of Paclitaxel. Clinical and Translational Science. 14(2). 568–581. 27 indexed citations
5.
Chang, Jonathan L., Sulggi A. Lee, Alexander C. Tsai, et al.. (2018). CYP2B6 Genetic Polymorphisms, Depression, and Viral Suppression in Adults Living with HIV Initiating Efavirenz-Containing Antiretroviral Therapy Regimens in Uganda: Pooled Analysis of Two Prospective Studies. AIDS Research and Human Retroviruses. 34(11). 982–992. 5 indexed citations
6.
Long-Boyle, Janel, Deborah French, Leslie Wilson, et al.. (2018). A practical first step using needs assessment and a survey approach to implementing a clinical pharmacogenomics consult service. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2(3). 214–221. 8 indexed citations
7.
Komatsu, Masaaki, Heather E. Wheeler, Suyoun Chung, et al.. (2015). Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy. Clinical Cancer Research. 21(19). 4337–4346. 36 indexed citations
8.
Baldwin, R. Michael, Kouros Owzar, Hitoshi Zembutsu, et al.. (2012). A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101. Clinical Cancer Research. 18(18). 5099–5109. 160 indexed citations
9.
Wheeler, Heather E., Eric R. Gamazon, Claudia Wing, et al.. (2012). Integration of Cell Line and Clinical Trial Genome-Wide Analyses Supports a Polygenic Architecture of Paclitaxel-Induced Sensory Peripheral Neuropathy. Clinical Cancer Research. 19(2). 491–499. 49 indexed citations
10.
Kelly, Libusha, Hisayo Fukushima, Rachel Karchin, et al.. (2010). Functional hot spots in human ATP‐binding cassette transporter nucleotide binding domains. Protein Science. 19(11). 2110–2121. 13 indexed citations
11.
Innocenti, Federico, Deanna L. Kroetz, Erin G. Schuetz, et al.. (2009). Comprehensive Pharmacogenetic Analysis of Irinotecan Neutropenia and Pharmacokinetics. Journal of Clinical Oncology. 27(16). 2604–2614. 200 indexed citations
12.
Kelly, Libusha, Ursula Pieper, Narayanan Eswar, et al.. (2009). A survey of integral α-helical membrane proteins. Journal of Structural and Functional Genomics. 10(4). 269–280. 12 indexed citations
13.
Abla, Nada, Leslie W. Chinn, Tsutomu Nakamura, et al.. (2008). The Human Multidrug Resistance Protein 4 (MRP4, ABCC4): Functional Analysis of a Highly Polymorphic Gene. Journal of Pharmacology and Experimental Therapeutics. 325(3). 859–868. 88 indexed citations
14.
Soranzo, Nicole, Libusha Kelly, Lillian Martinian, et al.. (2007). Lack of Support for a Role for RLIP76 (RALBP1) in Response to Treatment or Predisposition to Epilepsy. Epilepsia. 48(4). 674–683. 21 indexed citations
15.
Gow, Jason M., Leslie W. Chinn, & Deanna L. Kroetz. (2007). The Effects of ABCB1 3′-Untranslated Region Variants on mRNA Stability. Drug Metabolism and Disposition. 36(1). 10–15. 13 indexed citations
16.
Kroetz, Deanna L., H. L. McLeod, Lena E. Friberg, et al.. (2006). Irinotecan-induced Diarrhea: Functional Significance of the Polymorphic ABCC2 Transporter Protein. Clinical Pharmacology & Therapeutics. 81(1). 42–49. 131 indexed citations
17.
Nakamura, Tsutomu, Toshiyuki Sakaeda, Deanna L. Kroetz, et al.. (2006). MDR1 Haplotype Frequencies in Japanese and Caucasian, and in Japanese Patients with Colorectal Cancer and Esophageal Cancer. Drug Metabolism and Pharmacokinetics. 21(2). 126–132. 82 indexed citations
18.
Xu, Fengyun, Valerie Y. Ng, Deanna L. Kroetz, & Paul R. Ortiz de Montellano. (2006). CYP4 Isoform Specificity in the ω-Hydroxylation of Phytanic Acid, a Potential Route to Elimination of the Causative Agent of Refsum’s Disease. Journal of Pharmacology and Experimental Therapeutics. 318(2). 835–839. 13 indexed citations
19.
Magnus, Carew, et al.. (2002). No effect of MDR1 C3435T polymorphism on disposition and CNS effects of loperamide. Clinical Pharmacology & Therapeutics. 71(2). 72. 8 indexed citations
20.
Kroetz, Deanna L., Bradley M. Kerr, Lynne V. McFarland, et al.. (1993). Measurement of in vivo microsomal epoxide hydrolase activity in white subjects. Clinical Pharmacology & Therapeutics. 53(3). 306–315. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026